N/A N=81 Randomized Single-blind Treatment

Memory and Fear Study (Fear of Memory Loss Study)

Anxiety and Fear

Bottom Line

View on ClinicalTrials.gov: NCT04821960 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2024

Primary outcome: Primary: Fear and Avoidance of Memory Loss (FAM) Scale Score at Follow-up — 63.9; 60.3 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Tailored Mindfulness Program for Fear of Memory Loss (Behavioral); Conventional Mindfulness Program (Behavioral)
Age: Adult, Older Adult · 55+ yrs
Sex: All
Sponsor: Northwestern University
Primary completion: Jun 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Fear and Avoidance of Memory Loss (FAM) Scale Score at Follow-up	63.9; 60.3	—
PRIMARY Fear of Alzheimer's Disease Scale (FADS) Score at Follow-up	47.3; 45.2	—
SECONDARY Memory Failure Scale (MFS)	34.9; 32.2	—

Summary

This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.

Eligibility Criteria

Inclusion Criteria

55 years of age or older
Elevated dementia-related fear
Able to read/write in English
Willingness to be randomized to intervention group
Willingness to complete three weeks of self-guided intervention, questionnaires, and cognitive tests.
Access to a reliable internet connection

Exclusion Criteria

Diagnosis of mild cognitive impairment, Alzheimer's Disease, or dementia by a healthcare provider.
Impaired cognitive or neurologic function
Unstable medical condition
Severe depression
Current treatment for anxiety or depression
Current participation in another psychotherapy
Current use of psychiatric medication
Current substance use disorder
Inadequate vision or hearing to interact with study materials

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04821960). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.